By CBJ
LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — Sernova Biotherapeutics (鈥淪ernova鈥) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals, Inc. (鈥淓ledon鈥) (Nasdaq: ELDN) to evaluate Eledon鈥檚 immunosuppressive agent tegoprubart (AT-1501) in Sernova鈥檚 ongoing Phase 1/2 clinical trial of its Cell Pouch Bio-hybrid Organ in patients with type 1 […]